1/31
03:52 pm
iobt
IO Biotech Provides Corporate Update [Yahoo! Finance]
Low
Report
IO Biotech Provides Corporate Update [Yahoo! Finance]
1/30
08:05 am
iobt
IO Biotech Provides Corporate Update
Medium
Report
IO Biotech Provides Corporate Update
1/26
04:02 am
iobt
IO Biotech (NASDAQ:IOBT) was given a new $0.50 price target on by analysts at Piper Sandler.
Medium
Report
IO Biotech (NASDAQ:IOBT) was given a new $0.50 price target on by analysts at Piper Sandler.
1/23
08:08 pm
iobt
IO Biotech (NASDAQ:IOBT) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating.
High
Report
IO Biotech (NASDAQ:IOBT) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating.
1/21
05:30 am
iobt
IO Biotech Announces Exploration of Strategic Alternatives
High
Report
IO Biotech Announces Exploration of Strategic Alternatives
1/10
01:07 am
iobt
High
Report
1/8
07:09 am
iobt
IO Biotech (NASDAQ:IOBT) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "underweight" rating.
Medium
Report
IO Biotech (NASDAQ:IOBT) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "underweight" rating.
12/29
01:08 am
iobt
12/21
01:08 am
iobt
Medium
Report
12/16
04:38 pm
iobt
IO Biotech (NASDAQ:IOBT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
IO Biotech (NASDAQ:IOBT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/15
04:21 pm
iobt
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications [Yahoo! Finance]
Medium
Report
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications [Yahoo! Finance]
12/15
04:05 pm
iobt
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
Low
Report
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications